FGF23 and chronic kidney disease: Dysregulation of the FGF23—α-Klotho network already occurs at earlier CKD stages, where abnormal levels of calcium and phosphate, inflammation, increased apoptosis, and depletion of calcification inhibitors results in the promotion of an active calcification process (91, 92).